Myoclonus-dystonia syndrome:: ε-sarcoglycan mutations and phenotype

被引:105
作者
Asmus, F
Zimprich, A
du Montcel, ST
Kabus, C
Deuschl, G
Kupsch, A
Ziemann, U
Castro, M
Kühn, AA
Strom, TM
Vidailhet, M
Bhatia, KP
Dürr, A
Wood, NW
Brice, A
Gasser, T
机构
[1] Univ Munich, Neurol Klin Grosshadern, D-81377 Munich, Germany
[2] Hop La Pitie Salpetriere, Serv Informat Med, Paris, France
[3] Jud Krankenhaus, Neurol Abt, Berlin, Germany
[4] Univ Kiel, Neurol Klin, D-2300 Kiel, Germany
[5] Humboldt Univ, Neurol Klin, Berlin, Germany
[6] Goethe Univ Frankfurt, Neurol Klin, Frankfurt, Germany
[7] Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany
[8] GSF Munich, Natl Res Ctr, Munich, Germany
[9] Hop St Antoine, Serv Neurol, Paris, France
[10] Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England
[11] UCL Natl Hosp Neurol, London, England
[12] Hop La Pitie Salpetriere, INSERM, U289, Paris, France
关键词
D O I
10.1002/ana.10325
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the gene for epsilon-sarcoglycan (SGCE) have been found to cause myoclonus-dystonia syndrome. We now report clinical and genetic findings in nine additional European families with myoclonus-dystonia syndrome. The clinical presentation in 24 affecteds was homogeneous with myoclonus predominantly of neck and upper limbs in 23 of them and dystonia, presenting as cervical dystonia and/or writer's cramp, in 13 cases. Six novel and one previously known heterozygous SGCE mutations were identified. SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus-dystonia syndrome.
引用
收藏
页码:489 / 492
页数:4
相关论文
共 19 条
[1]  
Asmus F, 2001, ANN NEUROL, V49, P121, DOI 10.1002/1531-8249(200101)49:1<121::AID-ANA20>3.0.CO
[2]  
2-8
[3]   The DYT1 phenotype and guidelines for diagnostic testing [J].
Bressman, SB ;
Sabatti, C ;
Raymond, D ;
de Leon, D ;
Klein, C ;
Kramer, PL ;
Brin, MF ;
Fahn, S ;
Breakefield, X ;
Ozelius, LJ ;
Risch, NJ .
NEUROLOGY, 2000, 54 (09) :1746-1752
[4]   Abnormally spliced β-globin mRNAs:: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay [J].
Danckwardt, S ;
Neu-Yilik, G ;
Thermann, R ;
Frede, U ;
Hentze, MW ;
Kulozik, AE .
BLOOD, 2002, 99 (05) :1811-1816
[5]   ε-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D [J].
Ettinger, AJ ;
Feng, GP ;
Sanes, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32534-32538
[6]  
Gasser T, 1998, Adv Neurol, V78, P325
[7]  
Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO
[8]  
2-T
[9]   A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system [J].
Imamura, M ;
Araishi, K ;
Noguchi, S ;
Ozawa, E .
HUMAN MOLECULAR GENETICS, 2000, 9 (20) :3091-3100
[10]  
Klein C, 2000, AM J HUM GENET, V67, P1314